Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FACBC PET-CT for Post-Prostatectomy Radiotherapy
NCT01666808Phase 3Completed
- Sponsor
- Emory University
- Start
- Sep 2012
- Primary completion
- Apr 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of fluciclovine f 18 in prostate cancer (PCa), sponsored by Emory University. Started Sep 2012; status: completed.
02
Drugs
fluciclovine f 18
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT01666808.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01666808.